Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)
Others
Ratios

NewAmsterdam Pharma Co N.V (NAMS) Shares Outstanding (Diluted Average): 2022-2023

  • NewAmsterdam Pharma Co N.V's Shares Outstanding (Diluted Average) was N/A to $1.00 in Q2 2023 from the same period last year, while for Jun 2023 it was $1.00, marking a year-over-year change of. This contributed to the annual value of $11.4 million for FY2022, which is N/A change from last year.
  • Latest data reveals that NewAmsterdam Pharma Co N.V reported Shares Outstanding (Diluted Average) of $1.00 as of Q2 2023, which was down 100.00% from $11.4 million recorded in Q4 2022.
  • NewAmsterdam Pharma Co N.V's 5-year Shares Outstanding (Diluted Average) high stood at $11.4 million for Q4 2022, and its period low was $1.00 during Q2 2023.
  • For the 2-year period, NewAmsterdam Pharma Co N.V's Shares Outstanding (Diluted Average) averaged around $5.7 million, with its median value being $5.7 million (2022).